IL2 and anaplastic large cell lymphoma: Moreover, further studies are urgently needed to examine the effects of eliminating the in vivo source of IL-2 and/or blocking IL-2 signaling in ALCL cells as a potential therapeutic approach to enhance current treatment for ALCL.